708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Ovarian cancer

708 Preclinical studies support therapeutic application of the leukaemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	41	0	10
Nov 2021	42	0	7
Dec 2021	9	0	1
Jan 2022	59	0	5
Feb 2022	10	0	0
Mar 2022	10	0	6
Apr 2022	7	0	7
May 2022	26	0	9
Jun 2022	12	0	3
Jul 2022	33	0	12
Aug 2022	7	0	6
Sep 2022	14	0	9
Oct 2022	20	0	5
Nov 2022	17	0	4
Dec 2022	22	0	6
Jan 2023	31	0	5
Feb 2023	18	0	0
Mar 2023	10	0	0
Total	388	0	95